Back to Search
JERRY HIRAGA, PHARM.D
PHARM.D
Pharmacist
NPI: 1861803611Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
31475(CA)
Research & Publications (7)
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.
PMID 19246561·Blood·2009
3-trial
Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome.
PMID 18217891·Br J Haematol·2008
8-other
Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy.
PMID 17675267·Int J Hematol·2007
5-case
Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
PMID 17443219·Leukemia·2007
8-other
Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
PMID 17050200·Int J Hematol·2006
8-other
Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma.
PMID 16757436·Int J Hematol·2006
8-other
A case of interstitial pneumonia induced by rituximab therapy.
PMID 15765788·Int J Hematol·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3001 TRAVIS BLVD.
FAIRFIELD, CA 94534 - Phone
- (707) 429-8310
Quick Facts
- NPI
- 1861803611
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile